Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 1
3(100.0%)
3Total
Phase 1(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06841770Phase 1Recruiting

A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury

Role: lead

NCT05919563Active Not Recruiting

LTFU Study of Subjects Who Received GRNOPC1

Role: lead

NCT05975424Active Not Recruiting

LTFU Study of Subjects With Cervical SCI Who Received AST-OPC1

Role: lead

NCT02302157Phase 1Completed

Dose Escalation Study of AST-OPC1 in Spinal Cord Injury

Role: lead

NCT01217008Phase 1Completed

Safety Study of GRNOPC1 in Spinal Cord Injury

Role: lead

All 5 trials loaded